Advanced search    

Search: authors:"R. J. Stevens"

8 papers found.
Use AND, OR, NOT, +word, -word, "long phrase", (parentheses) to fine-tune your search.

Experiments to investigate lift production mechanisms on pitching flat plates

) and * P. R. R. J. Stevens exo-planetary exploration (Young et al. 2000). MAVs can use flapping wing designs to take advantage of unsteady effects at low Reynolds numbers (Petricca et al. 2011

Metformin and mortality. Reply to Lund SS [letter]

Diabetes Trials Unit, Oxford Centre for Diabetes Endocrinology and Metabolism, University of Oxford , Oxford , UK 1 B. J. Cairns Cancer Epidemiology Unit, University of Oxford , Oxford , UK 2 R. J. Stevens ... Nordisk; and given lectures supported by Bayer, Lilly, Merck and Novo Nordisk. R. J. Stevens and B. J. Cairns have no conflicts of interest associated with this letter. Contribution statement RJS, BJC and

Estimating the effect of sulfonylurea on HbA1c in diabetes: a systematic review and meta-analysis

Aims/hypothesis Sulfonylureas are widely prescribed glucose-lowering medications for diabetes, but the extent to which they improve glycaemia is poorly documented. This systematic review evaluates how sulfonylurea treatment affects glycaemic control. Methods Medline, EMBASE, the Cochrane Library and clinical trials registries were searched to identify double-blinded randomised...

Impact of using a non-diabetes-specific risk calculator on eligibility for statin therapy in type 2 diabetes

Diabetes Study 1 R. J. Stevens Cancer Research UK Epidemiology Unit, University of Oxford , Oxford, UK Aims/hypothesis The aim of this study was to investigate the impact of using a non-diabetes-specific

Pancreatic cancer in type 1 and young-onset diabetes: systematic review and meta-analysis

We conducted a systematic review of the risk of pancreatic cancer in people with type 1 and young-onset diabetes. In three cohort and six case–control studies, the relative risk for pancreatic cancer in people with (vs without) diabetes was 2.00 (95% confidence interval 1.37–3.01) based on 39 cases with diabetes.

Cost-utility analyses of intensive blood glucose and tight blood pressure control in type 2 diabetes (UKPDS 72)

P. M. Clarke . A. M. Gray . A. Briggs . R. J. Stevens . D. R. Matthews . R. R. Holman . on behalf of the UK Prospective Diabetes Study (UKPDS) 0 0 P. M. Clarke Australian Centre for Diabetes

A model to estimate the lifetime health outcomes of patients with Type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68)

Aims/hypothesis The aim of this study was to develop a simulation model for Type 2 diabetes that can be used to estimate the likely occurrence of major diabetes-related complications over a lifetime, in order to calculate health economic outcomes such as quality-adjusted life expectancy. Methods Equations for forecasting the occurrence of seven diabetes-related complications and...